QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
Somnath Mishra
Advertisement
Somnath Mishra, [email protected], is president at Shabas Solutions LLC.
Articles by Somnath Mishra
QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
BioPhorum Unites 20 Organizations to Modernize Small Molecule Production
5